Impact of intravenous trehalose administration in patients with niemann-pick disease types a and b

HIGHLIGHTS

  • who: Moein Mobini et al. from the Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran have published the Article: Impact of Intravenous Trehalose Administration in Patients with Niemann-Pick Disease Types A and B, in the Journal: (JOURNAL)
  • what: This study reports clinical research aimed to investigate the efficacy of intravenous trehalose infusion (15 g/week) for a period of 12 weeks in five NPA and NPB patients. Furtherit can also induce the autophagy process via the mTOR-independent pathway in cells of the more, it can also . induce the process via thethe . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?